JK

John Michael Ketcham

MT Mirati Therapeutics: 5 patents #2 of 37Top 6%
AB Array Biopharma: 1 patents #29 of 63Top 50%
RT Rapt Therapeutics: 1 patents #1 of 10Top 10%
📍 San Diego, CA: #278 of 4,447 inventorsTop 7%
🗺 California: #2,806 of 65,961 inventorsTop 5%
Overall (2022): #22,066 of 548,613Top 5%
6
Patents 2022

Issued Patents 2022

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
11492351 MTA-cooperative PRMT5 inhibitors Thomas P. Bobinski, Christopher Ronald Smith, Matthew Arnold Marx, Aaron Craig Burns, John David Lawson +3 more 2022-11-08
11485738 Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors Matthew Arnold Marx, Matthew Lee, Thomas P. Bobinski, Aaron Craig Burns, Nidhi Arora +1 more 2022-11-01
11479551 MTA-cooperative PRMT5 inhibitors Thomas P. Bobinski, Christopher Ronald Smith, Matthew Arnold Marx, Aaron Craig Burns, John David Lawson +3 more 2022-10-25
11453683 KRas G12D inhibitors Xiaolun Wang, Aaron Craig Burns, James Gail Christensen, John David Lawson, Matthew Arnold Marx +21 more 2022-09-27
11384064 Chemokine receptor modulators and uses thereof Jeffrey J. Jackson, Akinori Okano, Maureen Kay Reilly, Omar Robles-Resendiz, Jacob Bradley Schwarz +4 more 2022-07-12
11220509 Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors Matthew Arnold Marx, Matthew Lee, Thomas P. Bobinski, Aaron Craig Burns, Nidhi Arora +1 more 2022-01-11